Neurogene (NGNE) Capital Expenditures (2013 - 2026)
Neurogene (NGNE) posted Capital Expenditures of $281000.0 for Q1 2026, up 128.7% on a QoQ basis from -$979000.0 in Q4 2025, and down 63.97% year-over-year from $780000.0 in Q1 2025.
Neurogene (NGNE) Capital Expenditures (2013 - 2026) Analysis & Trends
Neurogene's Capital Expenditures history runs 14 years deep, the most recent figure standing at $281000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 63.97% year-over-year to $281000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$423000.0 (down 130.99% YoY) and the FY2025 annual result came in at $76000.0, down 89.53% from the prior year.
- Capital Expenditures was $281000.0 for Q1 2026 at Neurogene, up from -$979000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q4 2022 and bottomed at -$979000.0 in Q4 2025.
- A 5-year average of $213764.7 and a median of $141000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 964.35% — and 2025, when it slumped 4356.52%.
- Neurogene's Capital Expenditures stood at $1.2 million in 2022, then slumped by 89.54% to $128000.0 in 2023, then tumbled by 82.03% to $23000.0 in 2024, then slumped by 4356.52% to -$979000.0 in 2025, then jumped by 128.7% to $281000.0 in 2026.
- Business Quant data shows NGNE's Capital Expenditures at $281000.0 in Q1 2026, -$979000.0 in Q4 2025, and $127000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,000.00 |
| Mar 31, 2026 | 281,000.00 |
| Dec 31, 2025 | -979,000.00 |
| Dec 31, 2025 | -979,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 128,000.00 |
| Dec 31, 2023 | 128,000.00 |